Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Poland Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20051
20062
20081
20101
20122
20131
20143
20151
20171
20181
20192
20206
20213
20221
20231
20243
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting7
Terminated5
Active, not recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx7
GlaxoSmithKline3
Novartis Pharmaceuticals3
UCB Biopharma SRL3
Amgen2
Chugai Pharmaceutical2
Rigel Pharmaceuticals2
Takeda2
Baxalta now part of Shire1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic38
Thrombocytopenia7
Purpura5
Blood Platelet Disorders3
Hematologic Diseases3
Antiphospholipid Syndrome2
Autoimmune Diseases2
Behcet Syndrome2
Cytopenia2
Dermatomyositis2

Trials

Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.